Hearing impairment during deferoxamine therapy for thalassemia major
J Pediatr
.
1991 May;118(5):826-7.
doi: 10.1016/s0022-3476(05)80063-0.
Authors
F Argiolu
,
G Diana
,
A Avignone
,
A Cao
,
S Di Ninni
PMID:
2019945
DOI:
10.1016/s0022-3476(05)80063-0
No abstract available
Publication types
Comment
Letter
MeSH terms
Adolescent
Child
Child, Preschool
Deferoxamine / adverse effects*
Hearing Loss, Sensorineural / chemically induced*
Humans
Thalassemia / complications*
Thalassemia / drug therapy
Substances
Deferoxamine